← Open Payments lookup

KEVIN NARDONE: Open Payments

NPI 1710469549 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,018 in 264 payments from 16 companies in 2025. Trend: 2023 $4,968 · 2024 $3,669 · 2025 $5,018

Food & beverage: $4,933Education: $85
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.53$1,187
Otsuka America Pharmaceutical, Inc.42$628
Alkermes, Inc.20$484
ABBVIE INC.47$475
E.R. Squibb & Sons, L.L.C.11$393
Vanda Pharmaceuticals Inc.26$358
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)22$355
Janssen Pharmaceuticals, Inc11$347
Supernus Pharmaceuticals, Inc.11$285
Lundbeck LLC12$215

Products named: AUSTEDO XR, REXULTI, VRAYLAR, UZEDY, COBENFY, CAPLYTA, FANAPT, Qelbree.

Industry payments across MA — which companies pay providers there.